Leadless Pacemaker CRT Coordination via Implant Communication
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional pacemakers with leads are associated with complications such as pocket hematoma, infection, and lead dislodgement, and existing methods for selecting CRT pacing parameters are time-consuming and poorly reproducible, limiting the effectiveness of Cardiac Resynchronization Therapy (CRT) in heart failure patients.
Innovation Solution
A leadless pacemaker system comprising three leadless pacemakers implanted in the right atrial, right ventricular, and left ventricular chambers, with one designated as the master, to measure P-wave duration, determine AV and VV delays, and coordinate CRT therapy without a central processor, using implant-to-implant communication to synchronize pacing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional pacemakers with leads are used to perform CRT, then multi-chamber cardiac pacing and sensing can be provided, but complications such as pocket hematoma, infection, and lead dislodgement occur
Solution Approach 1:
The patent removes the leads from the pacemaker system, extracting the harmful component that causes complications. The leadless pacemaker implant eliminates the need for transvenous leads, thereby preventing lead dislodgement, pocket hematoma, and infections associated with lead insertion and positioning.
Solution Approach 2:
The patent introduces an intermediary communication system between multiple leadless pacemakers. Since the pacemakers are physically separated and implanted in different cardiac chambers, they use wireless or conductive communication to coordinate their pacing actions, enabling synchronized multi-chamber CRT without physical lead connections.
2Measurement precision
If echocardiography based techniques are used to select CRT pacing parameters, then individualized CRT parameters can be obtained, but the process is very time consuming and poorly reproducible
Solution Approach 1:
The patent enables the pacemaker system to automatically determine optimal CRT parameters without requiring external echocardiography guidance. The device uses its own sensed cardiac signals and implanted sensors to autonomously select pacing parameters, eliminating the time-consuming and operator-dependent echocardiography process.
Solution Approach 2:
The patent implements feedback mechanisms where the pacemaker continuously monitors cardiac responses to pacing and automatically adjusts parameters. By sensing electrical and mechanical signals from the heart, the device provides real-time feedback to optimize CRT parameters, making the process reproducible and efficient.
3Adaptability or versatility
If a conventional pacemaker with three leads is used for CRT, then atrial and ventricular pacing can be delivered, but the device complexity and surgical implantation difficulty increase
Solution Approach 1:
The patent divides the single conventional pacemaker into multiple independent leadless pacemaker units, each implanted in a specific cardiac chamber. This segmentation simplifies the overall system by eliminating the need for a single complex device with multiple leads, while maintaining multi-chamber pacing capability through coordinated operation of the segmented units.
Solution Approach 2:
Each leadless pacemaker unit is designed to be universal and multi-functional, capable of performing both pacing and sensing functions in its designated chamber. This multi-functionality reduces the need for specialized components and simplifies the overall system architecture compared to a conventional pacemaker requiring separate leads for each function.
Data Source
AI summary
Cardiac pacing is performed using leadless pacemakers (LPs). An AV delay is determined based on a P-wave duration. When pacing occurs during cardiac cycles starting with intrinsic atrial events, the AV delay is set to the P-wave duration plus a first offset if the P-wave duration is greater than a first threshold duration, and the AV delay is set to the P-wave duration plus a second offset that is greater than the first offset, if the P-wave duration is less than the first threshold duration. When pacing occurs during cardiac cycles starting with paced atrial events, the AV delay is set to the P-wave duration plus a third offset, if the P-wave duration is greater than a second threshold duration, or is set to the P-wave duration plus a fourth offset that is greater than the third offset, if the P-wave duration is less than the second threshold duration.